Todd Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Todd Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$385K	Buy	6,350 +63	+1%	+$3.67K	0.01%	169
2025 Q4	$339K	Buy	6,287 +462	+8%	+$22.2K	0.01%	168
2025 Q3	$263K	Hold	5,825	–	–	0.01%	170
2025 Q2	$270K	Hold	5,825	–	–	0.01%	166
2025 Q1	$355K	Buy	5,825 +66	+1%	+$3.85K	0.01%	159
2024 Q4	$326K	Buy	+5,759	New	+$322K	0.01%	158
2024 Q2	–	Sell	-278,407	Closed	-$15.1M	–	211
2024 Q1	$15.1M	Sell	278,407 -262,538	-49%	-$13.4M	0.31%	137
2023 Q4	$27.8M	Sell	540,945 -18,325	-3%	-$962K	0.61%	72
2023 Q3	$32.5M	Buy	559,270 +6,193	+1%	+$379K	0.77%	43
2023 Q2	$35.4M	Sell	553,077 -2,006	-0.4%	-$135K	0.82%	39
2023 Q1	$38.5M	Sell	555,083 -13,534	-2%	-$955K	0.93%	30
2022 Q4	$40.9M	Sell	568,617 -1,505	-0.3%	-$113K	0.99%	23
2022 Q3	$40.5M	Buy	570,122 +42,676	+8%	+$3.1M	1.13%	17
2022 Q2	$40.6M	Buy	527,446 +35,113	+7%	+$2.67M	1.05%	15
2022 Q1	$36M	Buy	492,333 +141,606	+40%	+$9.51M	0.79%	42
2021 Q4	$21.9M	Sell	350,727 -17,568	-5%	-$1.03M	0.47%	100
2021 Q3	$21.8M	Sell	368,295 -2,280	-0.6%	-$150K	0.5%	89
2021 Q2	$24.8M	Buy	370,575 +969	+0.3%	+$63.2K	0.56%	80
2021 Q1	$23.3M	Sell	369,606 -168,037	-31%	-$10.5M	0.55%	83
2020 Q4	$33.4M	Sell	537,643 -2,545	-0.5%	-$156K	0.85%	38
2020 Q3	$32.6M	Buy	540,188 +26,785	+5%	+$1.61M	0.97%	27
2020 Q2	$30.2M	Buy	+513,403	New	+$30.7M	0.96%	25
2014 Q2	–	Sell	-5,306	Closed	-$276K	–	216
2014 Q1	$276K	Hold	5,306	–	–	0.01%	192
2013 Q4	$282K	Sell	5,306 -280	-5%	-$14.3K	0.01%	194
2013 Q3	$259K	Sell	5,586 -25,396	-82%	-$1.11M	0.01%	196
2013 Q2	$1.39M	Buy	+30,982	New	+$1.35M	0.05%	189

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Todd Asset Management's BMY Position: Q1 2026 in Review

Todd Asset Management increased its Bristol-Myers Squibb (BMY) stake by 1% in Q1 2026, buying an estimated $3.67K and bringing the position to 6,350 shares worth $385K. The position accounts for 0.01% of the portfolio, ranked #169.

Todd Asset Management first reported a position in BMY in Q2 2013 and has held it in 26 quarters since. The position peaked at $40.9M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Todd Asset Management held 6,350 shares of Bristol-Myers Squibb worth $385K as of Q1 2026.
Todd Asset Management bought 63 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.67K.
Bristol-Myers Squibb made up 0.01% of Todd Asset Management's portfolio in Q1 2026, its #169 holding.
Todd Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 26 quarters since.
Todd Asset Management's Bristol-Myers Squibb position peaked at $40.9M in Q4 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Todd Asset Management's 13F filing for Q1 2026, filed 12 May 2026.